WS
ALXN

Wedbush Securities’s Alexion Pharmaceuticals ALXN Stock Holding History

Wedbush Securities’s Portfolio ALXN Stock Details ALXN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-4,703
Closed -$864K – 1249
2021
Q2 		$864K Sell
4,703
-109
-2% -$18.7K 0.04% 403
2021
Q1 		$736K Sell
4,812
-1,119
-19% -$173K 0.04% 427
2020
Q4 		$927K Sell
5,931
-3,228
-35% -$415K 0.08% 261
2020
Q3 		$1.05M Sell
9,159
-154
-2% -$16.6K 0.1% 216
2020
Q2 		$1.04M Buy
9,313
+6,901
+286% +$733K 0.1% 211
2020
Q1 		$217K Sell
2,412
-181
-7% -$17.8K 0.03% 651
2019
Q4 		$280K Sell
2,593
-120
-4% -$12.8K 0.02% 709
2019
Q3 		$266K Buy
2,713
+159
+6% +$17.9K 0.03% 684
2019
Q2 		$335K Sell
2,554
-3,144
-55% -$405K 0.03% 588
2019
Q1 		$770K Buy
5,698
+231
+4% +$28.7K 0.08% 279
2018
Q4 		$532K Buy
5,467
+83
+2% +$9.81K 0.07% 330
2018
Q3 		$748K Buy
5,384
+60
+1% +$7.53K 0.08% 259
2018
Q2 		$661K Buy
5,324
+265
+5% +$31K 0.08% 295
2018
Q1 		$564K Buy
5,059
+212
+4% +$25.3K 0.07% 334
2017
Q4 		$580K Sell
4,847
-243
-5% -$29.6K 0.07% 330
2017
Q3 		$714K Sell
5,090
-287
-5% -$39K 0.09% 254
2017
Q2 		$654K Buy
5,377
+385
+8% +$44.8K 0.08% 293
2017
Q1 		$605K Sell
4,992
-100
-2% -$12.9K 0.08% 295
2016
Q4 		$623K Buy
5,092
+177
+4% +$21.7K 0.09% 268
2016
Q3 		$602K Buy
4,915
+29
+0.6% +$3.73K 0.09% 262
2016
Q2 		$570K Buy
4,886
+82
+2% +$11.6K 0.09% 251
2016
Q1 		$669K Buy
4,804
+367
+8% +$53.9K 0.12% 193
2015
Q4 		$846K Buy
4,437
+739
+20% +$129K 0.15% 143
2015
Q3 		$578K Buy
3,698
+148
+4% +$27K 0.12% 196
2015
Q2 		$642K Hold
3,550
– – 0.12% 209
2015
Q1 		$615K Hold
3,550
– – 0.1% 221
2014
Q4 		$657K Sell
3,550
-46
-1% -$8.52K 0.1% 196
2014
Q3 		$596K Hold
3,596
– – 0.09% 224
2014
Q2 		$562K Sell
3,596
-950
-21% -$150K 0.09% 238
2014
Q1 		$692K Hold
4,546
– – 0.12% 176
2013
Q4 		$604K Hold
4,546
– – 0.14% 169
2013
Q3 		$528K Hold
4,546
– – 0.14% 174
2013
Q2 		$419K Buy
+4,546
New +$438K 0.12% 221

Other funds holding ALXN

BCI
Brinker Capital Investments Berwyn, Pennsylvania $11.7B AUM 21.33% 1-Year Est. Return
NICM
Neo Ivy Capital Management New York $379M AUM 28.34% 1-Year Est. Return
TAIM
TD Ameritrade Investment Management Omaha, Nebraska $9.4B AUM 7.2% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $280B AUM 33.63% 1-Year Est. Return
RG
Retirement Group San Diego, California $279M AUM 22.21% 1-Year Est. Return
CFO
CVA Family Office Denver, Colorado $950M AUM 20.72% 1-Year Est. Return
MAM
Meeder Asset Management Dublin, Ohio $1.75B AUM 34.85% 1-Year Est. Return